Skip to main content

Table 3 Enzyme elevations in patients with myocardial infarction identified by the clinical events committee but not the site investigator*

From: Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study

  

Median peak CK/ULN

 

Median peak CK-MB/ULN

Region

n

(25th, 75th percentiles)

n

(25th, 75th percentiles)

Eastern Europe

172

0.6 (0.3, 1.2)

167

1.4 (1.2, 1.9)

Latin America

34

0.7 (0.4, 1.2)

34

2.0 (1.3, 2.6)

North America

112

1.6 (1.0, 3.1)

106

2.9 (1.5, 5.5)

Western Europe

202

0.7 (0.4, 2.0)

196

1.7 (1.2, 3.0)

Overall

520

0.9 (0.4, 1.9)

503

1.6 (1.2, 2.9)